Descriptor English: | Paroxetine | ||||
Descriptor Spanish: |
Paroxetina
| ||||
Descriptor Portuguese: | Paroxetina | ||||
Descriptor French: | Paroxétine | ||||
Entry term(s): |
Aropax BRL 29060 BRL-29060 BRL29060 FG 7051 FG-7051 FG7051 Paroxetine Acetate Paroxetine Hydrochloride Paroxetine Hydrochloride Anhydrous Paroxetine Hydrochloride Hemihydrate Paroxetine Hydrochloride, Hemihydrate Paroxetine Maleate Paroxetine, cis-(+)-Isomer Paroxetine, cis-(-)-Isomer Paroxetine, trans-(+)-Isomer Paxil Seroxat |
||||
Tree number(s): |
D03.383.621.600 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017374 | ||||
Scope note: | A serotonin uptake inhibitor that is effective in the treatment of depression. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Serotonin Uptake Inhibitors Inhibidores Selectivos de la Recaptación de Serotonina inhibidores selectivos de la recaptación de serotonina Inbiteurs sélectifs de la recapture de la sérotonine Inibidores Seletivos de Recaptação de Serotonina Antidepressive Agents, Second-Generation Antidepresivos de Segunda Generación Antidepressivos de Segunda Geração Antidépresseurs de seconde génération antidepresivos de segunda generación Cytochrome P-450 CYP2D6 Inhibitors Inhibidores del Citocromo P-450 CYP2D6 Inibidores do Citocromo P-450 CYP2D6 Inhibiteurs du cytochrome P-450 CYP2D6 inhibidores del citocromo P-450 CYP 2D6 |
||||
Registry Number: | 41VRH5220H | ||||
CAS Type 1 Name: | Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)- | ||||
Previous Indexing: |
Dioxolanes (1978-1982) Piperidines (1982-1992) |
||||
Public MeSH Note: | 1993; PAROXETINE was indexed under PIPERIDINES 1982-1992 and under DIOXOLANES 1978-1982 |
||||
History Note: | 1993 (1978) |
||||
DeCS ID: | 30623 | ||||
Unique ID: | D017374 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1993/01/01 | ||||
Date of Entry: | 1992/05/22 | ||||
Revision Date: | 2018/02/28 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Paroxetine
- Preferred
Aropax
- Narrower
BRL-29060
- Narrower
FG-7051
- Narrower
Paroxetine Acetate
- Narrower
Seroxat
- Narrower
Paroxetine Hydrochloride Anhydrous
- Narrower
Paroxetine Maleate
- Narrower
Paroxetine, cis-(+)-Isomer
- Narrower
Paroxetine, cis-(-)-Isomer
- Narrower
Paroxetine, trans-(+)-Isomer
- Narrower
Paxil
- Narrower
Paroxetine Hydrochloride Hemihydrate
- Narrower
Paroxetine Hydrochloride
- Narrower
Concept UI |
M0026386 |
Scope note | A serotonin uptake inhibitor that is effective in the treatment of depression. |
Preferred term | Paroxetine |
Concept UI |
M0363571 |
Preferred term | Aropax |
Concept UI |
M0363570 |
Preferred term | BRL-29060 |
Entry term(s) |
BRL 29060 BRL29060 |
Concept UI |
M0363572 |
Preferred term | FG-7051 |
Entry term(s) |
FG 7051 FG7051 |
Concept UI |
M0329209 |
Preferred term | Paroxetine Acetate |
Concept UI |
M0026388 |
Preferred term | Seroxat |
Concept UI |
M0582617 |
Preferred term | Paroxetine Hydrochloride Anhydrous |
Concept UI |
M0329208 |
Preferred term | Paroxetine Maleate |
Concept UI |
M0329204 |
Preferred term | Paroxetine, cis-(+)-Isomer |
Concept UI |
M0329205 |
Preferred term | Paroxetine, cis-(-)-Isomer |
Concept UI |
M0329207 |
Preferred term | Paroxetine, trans-(+)-Isomer |
Concept UI |
M0026387 |
Preferred term | Paxil |
Concept UI |
M000638648 |
Preferred term | Paroxetine Hydrochloride Hemihydrate |
Entry term(s) |
Paroxetine Hydrochloride, Hemihydrate |
Concept UI |
M0329211 |
Preferred term | Paroxetine Hydrochloride |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey